Albireo Receives European Marketing Authorization of Bylvay™ (odevixibat), the First Drug Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC)

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence